Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Preliminary results
T2 Biosystems, Inc. (TTOO) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/12/2023 8-K Quarterly results
10/12/2023 8-K Quarterly results
08/11/2023 8-K Quarterly results, Conference call transcript
Docs: "T2 Biosystems Announces Second Quarter 2023 Financial Results",
"Transcript of conference call held on August 7, 2023"
08/09/2023 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "T2 Biosystems Regains Compliance with Nasdaq's Market Value of Listed Securities Requirement LEXINGTON, Mass., August 9, 2023"
07/31/2023 8-K Quarterly results
07/20/2023 8-K Quarterly results
07/12/2023 8-K Quarterly results
07/06/2023 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Amendments to Articles of Incorporation ...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Certificate of Designation of Preferences, Rights and Limitations of Series A Preferred Stock",
"Certificate of Designation of Preferences, Rights and Limitations of Series B Convertible Preferred Stock",
"Purchase Agreement, by and between the Company and the Purchasers party thereto",
"Securities Purchase Agreement, by and between the Company and the Lenders party thereto",
"Consent to Term Loan Agreement, by and between the Company and CRG Servicing LLC, as administrative agent and collateral agent, and the lenders party thereto"
06/09/2023 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "T2 Biosystems Announces Clinical Collaboration with Vanderbilt University Medical Center to Implement and Evaluate the T2Bacteria Panel for Clinical Use"
05/25/2023 8-K Quarterly results, Conference call transcript
Docs: "T2 Biosystems Announces First Quarter 2023 Financial Results",
"Transcript of conference call held on May 23, 2023"
05/23/2023 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing  Interact...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION"
03/31/2023 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing  Interact...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION"
03/16/2023 8-K Quarterly results, Conference call transcript
Docs: "T2 Biosystems Announces Fourth Quarter and Full Year 2022 Financial Results",
"Transcript of conference call held on March 13, 2023"
02/13/2023 8-K Quarterly results
01/23/2023 8-K Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Results of Operations and Financi...
Docs: "T2 Biosystems Announces Preliminary Fourth Quarter and Full Year 2022 Financial Results"
11/25/2022 8-K Quarterly results
11/10/2022 8-K Quarterly results
11/07/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "HHS and the Cohen Foundation Name T2 Biosystems a Phase 1 Winner in LymeX Diagnostics Prize"
10/14/2022 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "T2 Biosystems Highlights Multiple New Studies Demonstrating Improved Rapid Detection Across Several Patient Populations"
10/13/2022 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "T2 Biosystems Announces Plan to Commercialize a Diagnostic Test for Early Lyme Disease"
10/12/2022 8-K Material Modifications to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Yea...
Docs: "Certificate of Amendment to Restated Certificate of Incorporation of T2 Biosystems, Inc",
"Certificate of Amendment to Restated Certificate of Incorporation of T2 Biosystems, Inc"
10/12/2022 8-K Results of Operations and Financial Condition, Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure,...
Docs: "T2 Biosystems Announces Preliminary Third Quarter 2022 Financial Results and Updates 2022 Financial Outlook",
"T2 Biosystems Announces Reverse Stock Split Effective Today"
09/30/2022 8-K Entry into a Material Definitive Agreement  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION"
09/30/2022 8-K Entry into a Material Definitive Agreement  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION"
08/30/2022 8-K Other Events  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION"
08/17/2022 8-K Quarterly results
08/09/2022 8-K Quarterly results
07/25/2022 8-K Quarterly results
07/11/2022 8-K Quarterly results
07/06/2022 8-K Quarterly results
06/10/2022 8-K Quarterly results
05/24/2022 8-K Quarterly results
05/11/2022 8-K Quarterly results
04/27/2022 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "T2 Biosystems Announces Submission for FDA Breakthrough Device Designation for T2Biothreat Panel"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy